Specimen validity testing in urine drug monitoring of medications and illicit drugs: Clinical implications

Kenneth L. Kirsh, Paul Christo, Howard Heit, Katherine Steffel, Steven D. Passik

Research output: Contribution to journalArticle

Abstract

Objective: To discuss the importance of specimen validity testing (SVT) in urine drug testing (UDT) and the clinical role it plays in identifying efforts to subvert the UDTprocess. Methods: A discussion of the clinical impact ofSVTis presented. Results: A discussion of pH, specific gravity, creatinine, and oxidation for monitoring the adulteration of UDT samples is presented along with the clinical significance of such tests. Significance: SVThas a significant place in healthcare efforts to measure patient adherence, behavior, and honesty in communication with clinicians. SVTis typically ordered by treating clinicians who use the results to make therapeutic decisions regarding specific medical problems of their patient, including those related to medication and illicit drug use. In the absence o/SVT, a healthcare provider may fail to identify a patient's adulteration of their urine sample in an attempt at deceiving the provider. Moreover, the presence of some underlying medical conditions may obfuscate the UDT results.

Original languageEnglish (US)
Pages (from-to)53-59
Number of pages7
JournalJournal of Opioid Management
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Drug Monitoring
Street Drugs
Urine
Drug Contamination
Specific Gravity
Patient Compliance
Pharmaceutical Preparations
Health Personnel
Creatinine
Communication
Delivery of Health Care
Therapeutics

Keywords

  • Adulteration
  • Behavior
  • Specimen validity
  • Urine drug testing

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Anesthesiology and Pain Medicine
  • Medicine(all)

Cite this

Specimen validity testing in urine drug monitoring of medications and illicit drugs : Clinical implications. / Kirsh, Kenneth L.; Christo, Paul; Heit, Howard; Steffel, Katherine; Passik, Steven D.

In: Journal of Opioid Management, Vol. 11, No. 1, 01.01.2015, p. 53-59.

Research output: Contribution to journalArticle

Kirsh, Kenneth L. ; Christo, Paul ; Heit, Howard ; Steffel, Katherine ; Passik, Steven D. / Specimen validity testing in urine drug monitoring of medications and illicit drugs : Clinical implications. In: Journal of Opioid Management. 2015 ; Vol. 11, No. 1. pp. 53-59.
@article{10849a98066c4dee903f2932fab0c2e4,
title = "Specimen validity testing in urine drug monitoring of medications and illicit drugs: Clinical implications",
abstract = "Objective: To discuss the importance of specimen validity testing (SVT) in urine drug testing (UDT) and the clinical role it plays in identifying efforts to subvert the UDTprocess. Methods: A discussion of the clinical impact ofSVTis presented. Results: A discussion of pH, specific gravity, creatinine, and oxidation for monitoring the adulteration of UDT samples is presented along with the clinical significance of such tests. Significance: SVThas a significant place in healthcare efforts to measure patient adherence, behavior, and honesty in communication with clinicians. SVTis typically ordered by treating clinicians who use the results to make therapeutic decisions regarding specific medical problems of their patient, including those related to medication and illicit drug use. In the absence o/SVT, a healthcare provider may fail to identify a patient's adulteration of their urine sample in an attempt at deceiving the provider. Moreover, the presence of some underlying medical conditions may obfuscate the UDT results.",
keywords = "Adulteration, Behavior, Specimen validity, Urine drug testing",
author = "Kirsh, {Kenneth L.} and Paul Christo and Howard Heit and Katherine Steffel and Passik, {Steven D.}",
year = "2015",
month = "1",
day = "1",
doi = "10.5055/jom.2015.0252",
language = "English (US)",
volume = "11",
pages = "53--59",
journal = "Journal of Opioid Management",
issn = "1551-7489",
publisher = "Weston Medical Publishing",
number = "1",

}

TY - JOUR

T1 - Specimen validity testing in urine drug monitoring of medications and illicit drugs

T2 - Clinical implications

AU - Kirsh, Kenneth L.

AU - Christo, Paul

AU - Heit, Howard

AU - Steffel, Katherine

AU - Passik, Steven D.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective: To discuss the importance of specimen validity testing (SVT) in urine drug testing (UDT) and the clinical role it plays in identifying efforts to subvert the UDTprocess. Methods: A discussion of the clinical impact ofSVTis presented. Results: A discussion of pH, specific gravity, creatinine, and oxidation for monitoring the adulteration of UDT samples is presented along with the clinical significance of such tests. Significance: SVThas a significant place in healthcare efforts to measure patient adherence, behavior, and honesty in communication with clinicians. SVTis typically ordered by treating clinicians who use the results to make therapeutic decisions regarding specific medical problems of their patient, including those related to medication and illicit drug use. In the absence o/SVT, a healthcare provider may fail to identify a patient's adulteration of their urine sample in an attempt at deceiving the provider. Moreover, the presence of some underlying medical conditions may obfuscate the UDT results.

AB - Objective: To discuss the importance of specimen validity testing (SVT) in urine drug testing (UDT) and the clinical role it plays in identifying efforts to subvert the UDTprocess. Methods: A discussion of the clinical impact ofSVTis presented. Results: A discussion of pH, specific gravity, creatinine, and oxidation for monitoring the adulteration of UDT samples is presented along with the clinical significance of such tests. Significance: SVThas a significant place in healthcare efforts to measure patient adherence, behavior, and honesty in communication with clinicians. SVTis typically ordered by treating clinicians who use the results to make therapeutic decisions regarding specific medical problems of their patient, including those related to medication and illicit drug use. In the absence o/SVT, a healthcare provider may fail to identify a patient's adulteration of their urine sample in an attempt at deceiving the provider. Moreover, the presence of some underlying medical conditions may obfuscate the UDT results.

KW - Adulteration

KW - Behavior

KW - Specimen validity

KW - Urine drug testing

UR - http://www.scopus.com/inward/record.url?scp=84929279077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929279077&partnerID=8YFLogxK

U2 - 10.5055/jom.2015.0252

DO - 10.5055/jom.2015.0252

M3 - Article

C2 - 25750165

AN - SCOPUS:84929279077

VL - 11

SP - 53

EP - 59

JO - Journal of Opioid Management

JF - Journal of Opioid Management

SN - 1551-7489

IS - 1

ER -